We are live on ! Find out more
ECYT

Endocyte, Inc. Common Stock
ECYT

Delisted

ECYT was delisted on the 20th of December, 2018.

Back to rankings

111 hedge funds and large institutions have $216M invested in Endocyte, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 111 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more call options, than puts

Call options by funds: $1.55M | Put options by funds: $822K

Holders
111
Holders Change
+111
Holders Change %
–
% of All Funds
3.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
111
Increased
–
Reduced
–
Closed
–
Calls
$1.55M
Puts
$822K
Net Calls
+$732K
Net Calls Change
+$732K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
76
VOYA Investment Management
Georgia
$305K +$313K +23,200 New
SCM
77
Sterling Capital Management
North Carolina
$304K +$312K +23,125 New
NFA
78
Nationwide Fund Advisors
Ohio
$298K +$306K +22,723 New
AIG
79
American International Group
New York
$268K +$275K +20,388 New
BA
80
BlackRock Advisors
Delaware
$244K +$251K +18,600 New
Citigroup
81
Citigroup
New York
$241K +$248K +18,386 New
HAMF
82
Hatteras Alternative Mutual Funds
North Carolina
$225K +$231K +17,160 New
WFM
83
Wilmington Funds Management
Delaware
$220K +$226K +16,730 New
Principal Financial Group
84
Principal Financial Group
Iowa
$211K +$217K +16,084 New
Ameriprise
85
Ameriprise
Minnesota
$196K +$201K +14,909 New
Goldman Sachs
86
Goldman Sachs
New York
$180K +$185K +13,729 New
Millennium Management
87
Millennium Management
New York
$179K +$183K +13,596 New
KeyBank National Association
88
KeyBank National Association
Ohio
$174K +$179K +13,244 New
PPA
89
Parametric Portfolio Associates
Washington
$169K +$173K +12,842 New
Bank of America
90
Bank of America
North Carolina
$154K +$159K +11,765 New
Susquehanna International Group
91
Susquehanna International Group
Pennsylvania
$154K +$159K +11,765 New
TD Asset Management
92
TD Asset Management
Ontario, Canada
$142K +$146K +10,800 New
BNP Paribas Financial Markets
93
BNP Paribas Financial Markets
France
$140K +$144K +10,658 New
JIC
94
Johnson Investment Counsel
Ohio
$139K +$144K +10,655 New
CBOA
95
Commonwealth Bank of Australia
Australia
$137K +$141K +10,440 New
MA
96
MUFG Americas
New York
$118K +$121K +9,000 New
Bank of Montreal
97
Bank of Montreal
Ontario, Canada
$86K +$87.6K +6,500 New
KIG
98
Kessler Investment Group
Indiana
$62K +$63.8K +4,730 New
ST
99
Spot Trading
Illinois
$55K +$56.6K +4,198 New
FQ
100
First Quadrant
California
$39K +$40.5K +3,000 New
1 2 3
4
5

ECYT Hedge Fund Activity: Q2 2013 in Review

111 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Endocyte, Inc. Common Stock (ECYT) for Q2 2013, worth a combined $216M.

Buyers outnumbered sellers: 111 funds opened new ECYT positions and 0 closed out — a net gain of 111 holders — while 0 added to existing stakes and 0 trimmed.

  • 111 institutional investors held Endocyte, Inc. Common Stock (ECYT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $216M of Endocyte, Inc. Common Stock stock for Q2 2013.
  • 111 funds opened new Endocyte, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +111 holders.

Based on aggregated 13F filings for Q2 2013.